A Transgenic Rat Model of Charcot-Marie-Tooth Disease
- 31 May 1996
- journal article
- Published by Elsevier BV in Neuron
- Vol. 16 (5), 1049-1060
- https://doi.org/10.1016/s0896-6273(00)80128-2
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Widespread expression of the peripheral myelin protein‐22 gene (pmp22) in neural and non‐neural tissues during murine developmentJournal of Neuroscience Research, 1995
- Molecular Basis of Common Hereditary Motor and Sensory Neuropathies in Humans and in Mouse ModelsBrain Pathology, 1995
- Peripheral Myelin Protein‐22 is Expressed in Rat and Mouse Brain and Spinal Cord MotoneuronsEuropean Journal of Neuroscience, 1995
- Elevated expression of messenger RNA for peripheral myelin protein 22 in biopsied peripheral nerves of patients with C Harcot‐Marie‐Tooth disease type 1AAnnals of Neurology, 1994
- Glial cell degeneration and hypomyelination caused by overexpression of myelin proteolipid protein geneNeuron, 1994
- Charcot-Marie-tooth disease: a new paradigm for the mechanism of inherited diseaseTrends in Genetics, 1994
- Peripheral myelin protein‐22 expression in charcot‐marie‐tooth disease type 1a sural nerve biopsiesJournal of Neuroscience Research, 1994
- Evidence for a recessive PMP22 point mutation in Charcot–Marie–Tooth disease type 1ANature Genetics, 1993
- Transgenic rats: new animal models in hypertension research. Invited lecture.Hypertension, 1991
- The effects of cAMP on differentiation of cultured Schwann cells: progression from an early phenotype (04+) to a myelin phenotype (P0+, GFAP-, N-CAM-, NGF-receptor-) depends on growth inhibition.The Journal of cell biology, 1991